
NephLong
Xelopes 40 mg Injection
Details
40 mg
-
Generic Name: Omeprazole
-
Strength: 40 mg/vial
-
Dosage Form: Intravenous (IV) Injection
Product Description:
Xelopes IV Injection contains Omeprazole, a proton pump inhibitor (PPI) that suppresses gastric acid secretion by inhibiting the H⁺/K⁺-ATPase enzyme system in the gastric parietal cells. It is used for short-term treatment of conditions such as gastric ulcers, duodenal ulcers, gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and other conditions where reduction of stomach acid is needed when oral administration is not feasible.
Dosage:
-
Adults:
-
Recommended dose is 40 mg once daily administered by slow intravenous injection over at least 2.5 minutes or as an infusion over 20–30 minutes.
-
Dosage may be adjusted based on the patient’s condition and medical judgment.
-
-
Reconstitution & Administration:
-
The vial should be reconstituted with 10 ml of 0.9% sodium chloride solution (normal saline) for IV injection.
-
For infusion, further dilute the reconstituted solution in 100 ml of sodium chloride or 5% dextrose.
-
Keto Nephron™ DS is a Medical Food as defined under 21 U.S.C. §360ee(b)(3) and 21 CFR 101.9(j)(8), formulated for the dietary management of Chronic Kidney Disease (CKD) Stages 3-5 in adults following physician-supervised protein-restricted diets. It is not a drug, not a dietary supplement, and is not intended for self-medication or general wellness use. MUST BE USED UNDER MEDICAL SUPERVISION. Quantum LifeSciences Inc., Claremont, CA 91711, USA. FDA Food Facility (Manufacturer) Reg. No. 14961463490.